CNS Disorders  >>  ispronicline (AZD3480)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

6 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ispronicline (AZD3480) / AstraZeneca
Sirocco, NCT00501111 / 2007-000835-24: Proof of Concept Study of Cognitive Improvement in Patients With Alzheimer's Disease

Completed
2b
659
Canada, Europe, RoW
AZD3480, Donepezil, Aricept
AstraZeneca
Alzheimer Disease
08/08
08/08
HALO, NCT00528905: Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia

Completed
2b
400
US, Canada
AZD3480
AstraZeneca
Schizophrenia
10/08
11/08
NCT00109564: A Safety and Efficacy Study of Ispronicline (TC-1734-112) in Subjects With Age Associated Memory Impairment (AAMI)

Completed
2
174
US
ispronicline (nicotinic acetylcholine receptor agonist)
Targacept Inc.
Age-Related Memory Disorders
 
10/05
NCT00683462: An Exploratory Trial of AZD3480 (TC-1734) for the Treatment of Adult Attention-Deficit/Hyperactivity Disorder (ADHD)

Completed
2
24
US
Placebo, AZD3480
AstraZeneca, Targacept Inc.
ADHD
 
07/09
NCT01466088 / 2011-000487-10: Efficacy, Safety, & Tolerability of AZD3480 Patients With Mild to Moderate Dementia of the Alzheimer's Type (AD)

Completed
2
386
US, Europe, RoW
Donepezil, Aricept, AZD3480, TC-1734
Targacept Inc.
Alzheimer's Disease
05/14
05/14
2006-004783-31: A Double-Blind, Randomised, Parallel-Group, Placebo-Controlled, MultiCentre, Phase IIa Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Ascending Multiple Oral Doses of AZD3480 in Schizophrenic Patients on Stable Antipsychotic Monotherapy with quetiapine, risperidone or olanzapine

Ongoing
2
50
Europe
AZD3480,
AstraZeneca AB
Schizophrenia
 
 

Download Options